Objective. The prevalence and distribution of extra-articular manifestations of rheumatoid arthritis (ExRA) and associated mortality were studied retrospectively in a cohort of RA patients admitted to University Hospital, Malmö , Sweden, during the period 1990-94.
Rheumatoid arthritis (RA) is a chronic, often severely require uniform and consistent ascertainment of such complications in a defined catchment area population. disabling disease, with a prevalence of roughly 1% in most populations [1] . Apart from the potentially RA is associated with an increased mortality, as compared to the general population [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Although a destructive joint manifestations of the disease, it is also characterized by systemic features. Severe weight loss few patients die of disease-specific complications, such as cervical instability or the side-effects of drugs [21], [2] and generalized osteoporosis [3] are often present in severe disease. Benign lymphadenopathy, a common the major part of the surplus mortality is due to other co-existing disease [17, 22] , particularly cardiovascular finding in active disease [4] , is an example of inflammation involving tissue outside the locomotor system. The disease [12, 17, 19, 20, 23] . Available data on the impact of ExRA on mortality in RA are contradictory. Extrarheumatoid nodule is another.
Some patients develop signs and symptoms of more articular mortality has been shown to be increased in some studies [7, [24] [25] [26] [27] , but not in the most recent one severe extra-articular inflammation in distant organs. These include pericarditis, pleuritis, Felty's syndrome [28] . The problem of referral bias when studying this aspect at major research centres has been emphasized and various manifestations of vasculitis, including the chronic 'rheumatoid' leg ulcers, which are thought to [29] . The aims of the present study were to investigate the be at least partly due to small-vessel vasculitis [5, 6 ] .
Extra-articular manifestations ( ExRA) are thought to period prevalence of the onset of extra-articular manifestations in a well-defined RA series, and their influence be particularly frequent in severe, active disease [7] . This subgroup of patients have been said to suffer from on mortality. 'malignant rheumatoid vasculitis' [8] . The frequency of ExRA is difficult to estimate. Most studies have been Materials and methods performed at highly specialized centres, with poorly defined catchment areas. Population studies of ExRA,
The study was carried out at University Hospital, Malmö , Sweden, the only secondary and tertiary facility on the other hand, are difficult to perform since they serving the city of Malmö (population~240 000 inhabitants). A computerized retrieval system was used to identify all patients with a registered diagnosis of RA (1 January 1990-30 June 1994). ( This period was chosen as data on diagnosis were available from the period a uniform manner from consultations recorded as free text. Interstitial lung disease, for example, a diagnosis after 1 January 1990, and work on the study was started in the autumn of 1994.) The medical records of these heavily dependent on the method of investigation [40] , was not included in the ExRA studied. patients were subjected to structured review by either of two of the authors (CT or UB). Of the 510 cases, 21
All cases of verified or suspected ExRA were reviewed by all three authors. When the presence of ExRA was were excluded as the diagnosis was patently incorrect (i.e. erroneous registration, premature diagnosis by an suspected, but there were insufficient data, additional records were obtained from primary care facilities, priinexperienced physician, etc.), or the case record did not contain enough data to support the diagnosis. Twenty vate practitioners, etc. The database of the department of dermatology was used to identify any cases of cutanepatients had a known history of previous extra-articular disease, leaving 469 previously non-ExRA patients ous vasculitis in the group with known RA. Potential cases were validated in a similar manner as mentioned who fulfilled the 1987 ACR (American College of Rheumatology) criteria for RA [30] to be included in above.
Patients with a known history of extra-articular manithe study.
The included patients were referred because of festations before the study period were not included in the ExRA group. Thus, the ExRA subgroup (n = 37) planned orthopaedic surgery (42.5% of referrals according to the register of all in-patient surgery), flares in consisted exclusively of patients with onset of ExRA during the studied period, the remaining 432 serving as disease activity, rehabilitation and also because of other, concomitant disease. They make up a significant part of controls. Dates of ExRA diagnosis and death were obtained from the case records, and causes of death the total number of individuals with RA in Malmö . As a part of the plan to construct a local register, an effort from the national register of death certificates (death certificates being available in all cases). For each partito identify all known cases with RA was made in 1996. After contacting all rheumatologists and general practicipant, the duration of observation was estimated from the date of first admittance to University Hospital, tioners in the city, 1150 patients were identified (L. Jacobsson, unpublished data), which corresponds to a Malmö , as in-patients, calculated from the starting date of the study (1 January 1990) until death or the end of prevalence of 0.5% in ages 20 yr and above, close to a recent prevalence estimate from Oslo, Norway [33] .
the study period (30 June 1994) . The duration of observation was registered separately as that without Hence, the studied 489 patients represent a substantial proportion (42%) of the known RA patients in the area.
previous ExRA during the study period and that after the onset of ExRA. Thus, patients who developed ExRA Diagnosed ExRA were identified from the case records using previously established criteria (see contributed to observation time in both subgroups.
To enable age-and sex-specific death rates, and overall Table 1 ). These criteria limit the ExRA studied to manifestations that are possible to evaluate retrospectively in age-sex-adjusted mortality in the series as a whole to be computed, the male and female subgroups were stratified separately by age into seven age groups [i.e. The number of previous admissions and proportion on steroid and DMARD treatment were calculated in the group of 37 cases of ExRA and in a group of 37 controls, matched for disease duration but otherwise blindly selected.
F. 1. Disease duration (after RA diagnosis) at onset of extra-articular manifestations. underlying cause, the ICD-9 system was used. There were 37 cases of onset of ExRA, an overall period prevalence of 7.9% (37/469). In 46% (17/37) of cases, the extra-articular manifestation was diagnosed at an out-patient facility. There was a small but nonsignificant over-representation of men ( Table 3 ). The the women ( Table 4) . Mortality rates were compared for each age group, and the age-sex-adjusted mortality median age of the future ExRA cases at the beginning of the observation period was 70.3 yr [interquartile (IQ) rate ratio was found to be 2.49 (95% CI 1.44-4.31). The expected survival rates for the two subgroups range 60.6-76.4], and at the time of first presentation of ExRA the median age was 72.0 yr (IQ range were calculated using age-specific mortality statistics for Malmö . The SMR was greater in the ExRA than in the 63.4-76.4). Age and disease duration were similar in the ExRA and non-ExRA subgroups ( Table 3) . The
There was a marked predominance of heart disease as the cause of death in both subgroups, although the onset of ExRA was unrelated to disease duration (since the diagnosis of RA), which ranged from 1 to 53 yr observed:expected ratio was higher in the ExRA subgroup ( Table 5 , Fig. 3 ). (Fig. 1) .
Mortality rates were greater among the men than Patients with ExRA had not been admitted as in-patients more frequently before the beginning of the among the women. In all, 13 deaths occurred/56.2 pyr in the ExRA subgroup and 106/1211.6 pyr in the nonstudy than non-ExRA controls, matched for disease duration. They were treated to an equal extent with ExRA subgroup. This corresponds to 1 death/4.3 pyr in the ExRA subgroup and 1 death/11.4 pyr in the nondisease-modifying anti-rheumatic drugs (DMARDs) at the beginning of the study, but more frequently with ExRA subgroup. The excess mortality associated with ExRA tended to be greater among the men than among steroids than the controls ( Table 2) . Mortality in the ExRA subgroup was not only greater than that in the age-matched general population, but found in a study of survival among hospitalized patients also greater than that in the non-ExRA subgroup, who, with rheumatoid pericarditis [25] . At first glance, the it should be borne in mind, were also treated at the close conjunction between the onset of ExRA and death hospital. If RA mortality is related to disease severity, might be interpreted as suggesting a very direct link as suggested by findings in some studies [16, [34] [35] [36] , the difference in mortality between the present ExRA The increased mortality associated with extra-articular 9 2.4 40 24 Heart disease disease was demonstrated in a well-defined group of  hospitalized patients, making up about one-third of the total number of subjects with RA in the city of Malmö From the Kaplan-Meier survival curve ( Fig. 2) , it is apparent that the major part of excess mortality in the Other 3 1.9 44 18 ExRA subgroup occurred soon after the onset of extraarticular manifestations. An analogous pattern was ICD, International Classification of Diseases.
between the two. However, another possible interpretagation used [40] . As the presence or absence of ILD is extremely difficult to evaluate retrospectively when no tion is that the excess mortality is at least to some extent related to recent hospitalization, a quite valid alternative standardized diagnostic criteria have been used, we chose not to include ILD in the extra-articular maniinterpretation which highlights the drawbacks of studying mortality in hospitalized cohorts. However, the festations studied. The extra-articular manifestations found in this series present study was not solely based on ExRA diagnosed at hospital, but was a retrospective study of the occurof RA patients were characterized by a predominance of serositis and cutaneous vasculitis. Pleuritis was more rence of ExRA during a limited period in a series of patients, one of whose common denominators was common than pericarditis, as also found by others in studies of Scandinavian RA patients [41, 42] . Although having been hospitalized for RA at sometime during the period. In fact, in a substantial part of the cases (46%), present in a few cases, manifestations associated with 'malignant rheumatoid arthritis' [8] (e.g. mononeuritis the extra-articular manifestation was diagnosed at an out-patient facility.
multiplex, scleritis and internal organ vasculitis) were infrequent findings. The excess mortality associated with extra-articular manifestations tended to be greater in men than in
The overall period prevalence of onset of extraarticular manifestations in the series was 7.9%. In all women, as has been reported by others [43] . Taken together with a slight over-representation of ExRA in likelihood, the extra-articular manifestations detected represent the major part of such manifestations in the men, it suggests an importance of sex hormones or other gender-specific risk factors in the development and population of Malmö as a whole (i.e. 240 000, adult population 188 000), as it is reasonable to suppose most course of extra-articular disease.
The definition of extra-articular manifestations merits patients with severe ExRA to have required hospital care and thus to have been included in the study. Thus, consideration. In autopsy series, a large proportion of RA patients have been found to manifest signs of the 37 cases of ExRA detected during this 4.5 yr period would correspond to an annual incidence of 44/million inflammation in the pleura and pericardium that are compatible with rheumatoid serositis [37] . Thus, extraadults (95% CI 32-62). The annual incidence of systemic rheumatoid vasculitis (SRV ), according to Scott and articular manifestations may be the rule rather than the exception in RA.
Bacon criteria [27] , was 7.1/million adults (95% CI 2.7-16.1). In reality, these incidence rates are probably Owing to the retrospective nature of the study, we found it convenient to include in the ExRA subgroup somewhat higher, as a few patients with ExRA may never have been admitted to the hospital during the only patients with signs and symptoms that had given rise to a suspicion of extra-articular manifestations, and study period. The annual incidence of SRV found in this study should be compared to the recent observations where this had been objectively verified (see Table 1 ). Hence, only patients with manifest disease were included in Norfolk, UK, where an annual incidence of 12.5/million adults was found [43] . in the ExRA subgroup, and thus some patients with less obvious ExRA may have been classified as non-ExRA.
As has been reported by others [7] , ExRA was not correlated with disease duration or disease stage. If anything, however, such misclassification would tend to reduce differences between the subgroups.
Patients with ExRA were on steroid treatment to a greater extent at the beginning of the study than nonOn the other hand, some authors have included only patients with a clinical suspicion verified by a histopathoExRA controls. The cause and importance of this difference are not clear, but our own data seem to indicate logical finding of vasculitis in biopsy material [28] . Although that approach is useful in the sense that it that patients who later develop ExRA have a tendency to a more rapid disease progression in the first years reduces the risk of including patients with non-RArelated manifestations, it may also bias the findings in after diagnosis, which may lead to a more frequent use of glucocorticosteroids (L. Turesson, unpublished the series as a whole in a different way. Inclusion of only patients with such a well-established diagnosis may results). However, patients who later developed ExRA were not admitted more frequently before the beginning result in a selection of long-term survivors, by excluding some severely ill or rapidly deteriorating patients.
of the study. What is the nature of the excess mortality observed? Rheumatoid nodules, secondary Sjö gren's syndrome and Raynaud's phenomenon are, by definition, extraAlthough the absolute number of deaths in the patients with ExRA was limited, there was a marked predominarticular manifestations. In a previous study by others [24] , no increase in mortality was found in patients with ance of heart disease as the cause of death. A similar, but less marked, trend was observed in the non-ExRA isolated nodules, Sjö gren's syndrome or Raynaud's phenomenon, whereas mortality was increased among subgroup. Several studies have shown cardiovascular disease to account for the major part of excess mortality patients with other manifestations.
Interstitial lung disease (ILD) is another extrain RA [12, 17, 19, 20, 23] . In a study of patients with severe rheumatoid vasculitis [8] , cardiovascular articular manifestation of RA [38] . Some available evidence suggests that the presence of ILD may have an co-morbidity was found to be more frequent than in RA controls without vasculitis. important impact on prognosis [39] . Figures for the prevalence of ILD among RA patients have been shown Laboratory investigations have yielded support for the hypothesis that inflammation may be an important to vary markedly, depending on the method of investi-
